SUPERNOVA Results Published
Results of the SUPERNOVA trial, worked on by Dr Oliver Koch and the CIRG team, have been published in The Lancet.
Exciting news as The Lancet journal publish the results of the SUPERNOVA trial
AstraZeneca conducted their SUPERNOVA trial across a 100+ sites around the world to evaluate AZD3152, now named sipavibart, for prevention of symptomatic COVID-19 in immunocompromised participants. The article in The Lancet documents the findings ofthe preliminary analysis from the trial which looked at the efficacy and safety of sipavibart .
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00804-1/fulltext#app-1
